[Long term study of a new antidiabetic agent in 1183 cases].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003517:Cyclopentanes / Q000031:analogs & derivatives / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D003517:Cyclopentanes; D007004:Hypoglycemic Agents; D011758:Pyrroles; D013453:Sulfonylurea Compounds
Etude à long terme d'un nouvel agent antidiabétique sur une population de 1183 cas